Back
Enliven Therapeutics 10K Form
Buy
66
ELVN
Enliven Therapeutics
Last Price:
23.81
Seasonality Move:
-10.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ELVN News And Ratings
See the #1 stock for the next 7 days that we like better than ELVN
ELVN Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-23.38M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.79 |
| Price / Book: | 3.55 |
Profitability
| EPS (TTM): | -1.92000 |
|---|---|
| Net Income (TTM): | $-79.6M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Enliven Therapeutics Earnings Forecast
Key Enliven Therapeutics Financial Ratios
- Per Share Earnings over the last 4 years have been positive in 0 years.
Enliven Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ELVN |
| Website: | enliventherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ELVN Technical Analysis vs Fundamental Analysis
Buy
66
Enliven Therapeutics (ELVN)
is a Buy
Is Enliven Therapeutics a Buy or a Sell?
-
Enliven Therapeutics stock is rated a Buy
The current Enliven Therapeutics [ELVN] share price is $24.00. The Score for ELVN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.